NCT03887078

Brief Summary

Mobile technologies/smartphone applications offer a means to effect behavior change without significant obstacles that typically limit implementation of empirically supported therapies (e.g., in-person sessions); however, rigorous research on apps is limited, and high-quality, adequately powered, randomized controlled trials with large samples are required. As more Americans consider bariatric surgery for the treatment of severe obesity, it is imperative to improve factors influencing suboptimal surgical outcomes (e.g., failure to adhere to diet and exercise recommendations and psychosocial impairment). This study will evaluate the effect of the Noom Coach for Bariatric Health platform in improving standard interventions utilized in bariatric surgery programs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable obesity

Timeline
Completed

Started Sep 2018

Typical duration for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 14, 2018

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 17, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 22, 2019

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 7, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 7, 2021

Completed
Last Updated

May 22, 2023

Status Verified

May 1, 2023

Enrollment Period

3 years

First QC Date

March 17, 2019

Last Update Submit

May 19, 2023

Conditions

Keywords

ObesityBariatric SurgerymHealth

Outcome Measures

Primary Outcomes (5)

  • Change in adherence to dietary recommendations

    Change in adherence to recommendations provided within pre-bariatric surgery program will be assessed using the ASA-24 interview. The interview is a 24-hr recall of all food and drink consumed. This interview will serve as the basis for measuring the adherence to dietary recommendations.

    Baseline, 8 weeks, 3 months, and 12 months

  • Change in adherence to physical activity recommendations (Activity Tracker)

    Change in adherence to physical activity recommendations will be measured using information collected from each participants activity tracker (FitBit). The activity tracker records number of steps taken each day and any physical activity performed.

    Baseline, 8 weeks, 3 months, and 12 months

  • Change in adherence to physical activity recommendations (IPAQ)

    Change in adherence to physical activity recommendations will also be measured using self reported physical activity using the International Physical Activity Questionnaire (IPAQ) The IPAQ is a 27- item questionnaire that assesses physical activity over the past week as a part of everyday activity, activity as a part of work, and activity as recreation. Scores include both minutes and days spent doing physical activity with higher scores indicating more time spent doing these activities. The measure can be scored categorically (low, moderate, high) or continuously using a defined scoring protocol.

    Baseline, 8 weeks, 3, 6, 9, and 12 months

  • Anthropometric changes (weight)

    To calculate trajectories of BMI, measures of height (inches) and weight (pounds) will be obtained at all in-person visits.

    Baseline, 8 weeks, 3, 6, and 12 months

  • Anthropometric changes (height)

    To calculate trajectories of BMI, measures of height (inches) and weight (pounds) will be obtained at all in-person visits.

    Baseline, 8 weeks, 3, 6, and 12 months

Secondary Outcomes (3)

  • Eating Disorder Examination Questionnaire (EDE-Q)

    Baseline, 8 weeks, 3, 6, 9, and 12 months

  • Depression Anxiety Stress Scales (DASS)

    Baseline, 8 weeks, 3, 6, 9, and 12 months

  • Short Form-36 Health Survey (SF-36)

    Baseline, 8 weeks, 3, 6, 9, and 12 months

Study Arms (8)

A. Presurgery Noom Bariatric + Augmentation Noom Bariatric

EXPERIMENTAL

Self-monitoring will be conducted through Noom Coach for Bariatric Health, and individuals will receive a specialized set of instructions on how to use the app. Intervention responsive individuals will be randomized post-surgery to Noom Bariatric augmentation.

Behavioral: Noom Coach for Bariatric Health

B. Presurgery Noom Bariatric + Augmentation Standard Care

EXPERIMENTAL

Self-monitoring will be conducted through Noom Coach for Bariatric Health, and individuals will receive a specialized set of instructions on how to use the app. Intervention responsive individuals will be randomized post-surgery to "usual care" in which participants are free to seek any assistance for their bariatric post-surgery care during the study period.

Behavioral: Noom Coach for Bariatric Health

C. Presurgery Noom Bariatric + Augmentation Noom Bariatric

EXPERIMENTAL

Self-monitoring will be conducted through Noom Coach for Bariatric Health, and individuals will receive a specialized set of instructions on how to use the app. Intervention non-responsive individuals will be randomized post-surgery to Noom Bariatric augmentation.

Behavioral: Noom Coach for Bariatric Health

D. Presurgery Noom Bariatric + Augmentation Standard Care

EXPERIMENTAL

Self-monitoring will be conducted through Noom Coach for Bariatric Health, and individuals will receive a specialized set of instructions on how to use the app. Intervention non-responsive individuals will be randomized post-surgery to "usual care" in which participants are free to seek any assistance for their bariatric post-surgery care during the study period.

Behavioral: Noom Coach for Bariatric Health

E. Pre-surgery Standard Care + Augmentation Noom Bariatric

EXPERIMENTAL

The control group will be a "usual care" condition in which participants are free to seek any assistance for their bariatric surgery care during the study period. Usual care responsive individuals will be randomized post-surgery to Noom Bariatric augmentation.

Behavioral: Noom Coach for Bariatric Health

F. Pre-surgery Standard Care + Augmentation Standard Care

NO INTERVENTION

The control group will be a "usual care" condition in which participants are free to seek any assistance for their bariatric surgery care during the study period. Usual care responsive individuals will be randomized post-surgery to usual care.

G. Pre-surgery Standard Care + Augmentation Noom Bariatric

EXPERIMENTAL

The control group will be a "usual care" condition in which participants are free to seek any assistance for their bariatric surgery care during the study period. Usual care non-responsive individuals will be randomized post-surgery to Noom Bariatric augmentation.

Behavioral: Noom Coach for Bariatric Health

H. Pre-surgery Standard Care + Augmentation Standard Care

NO INTERVENTION

The control group will be a "usual care" condition in which participants are free to seek any assistance for their bariatric surgery care during the study period. Usual care non-responsive individuals will be randomized post-surgery to usual care.

Interventions

Noom Coach for Bariatric Health offers a sustainable, low-cost, coach-led intervention, and an innovative solution to issues with pre-bariatric surgery weight loss. The intervention will take place over 8 weeks pre and or post-surgery.

A. Presurgery Noom Bariatric + Augmentation Noom BariatricB. Presurgery Noom Bariatric + Augmentation Standard CareC. Presurgery Noom Bariatric + Augmentation Noom BariatricD. Presurgery Noom Bariatric + Augmentation Standard CareE. Pre-surgery Standard Care + Augmentation Noom BariatricG. Pre-surgery Standard Care + Augmentation Noom Bariatric

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Enrolled in: (1) the Metabolic, Endocrine, and Minimally Invasive Surgery Division at Mount Sinai and planning to receive a bariatric procedure.
  • Between the ages of 18 and 60 at entry to the study.
  • Speak English.

You may not qualify if:

  • Clinically significant cognitive limitations (Wechsler Abbreviated Scale of Intelligence IQ Estimate \< 70) or history of developmental disability.
  • History of neurological disorder or injury (e.g., seizure disorder or moderate or severe head injury with \>10 minutes loss of consciousness).
  • Current/lifetime DSM-5 bipolar disorder, schizophrenia, or psychotic disorder.
  • Acute suicide risk.
  • Current DSM-5 alcohol or substance use disorder.
  • Pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Icahn School of Medicine at Mount Sinai

New York, New York, 10029, United States

Location

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Tom Hildebrandt, PsyD

    Icahn School of Medicine at Mount Sinai

    PRINCIPAL INVESTIGATOR
  • Andreas Michaelides, PhD

    Noom Inc.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Model Details: Two successive randomizations based on patterned response to primary intervention. Pre-surgical participants (n=200) will be randomized to groups in Noom Coach for Bariatric Health or standard care pre-surgery. Post-surgery, optimal and suboptimal responders will be randomized to Noom Bariatric or standard care. This design allows for comparisons between all 8 conditions. Contrasts allow us to answer the critical question about main effects of Noom Pre-surgery and Noom augmentation and whether this augmentation effect differs based on empirically derived classification of early response.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 17, 2019

First Posted

March 22, 2019

Study Start

September 14, 2018

Primary Completion

September 7, 2021

Study Completion

September 7, 2021

Last Updated

May 22, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations